News

NeuroPace Prepares to Share Breakthrough Study Insights

NeuroPace Prepares to Share Breakthrough Study Insights

NeuroPace Prepares for AAN 2025 Annual Meeting

MOUNTAIN VIEW, Calif. — NeuroPace, Inc. (NASDAQ: NPCE), a pioneering medical device company, is gearing up for an impactful presence at the upcoming American Academy of Neurology (AAN) Annual Meeting in San Diego. From April 5 to 9, the company will shed light on significant data derived from their Post-Approval Study (PAS) focusing on the RNS System, which is tailored for adults battling drug-resistant focal epilepsy (DRE).

Transforming Lives with Innovative Solutions

Living with drug-resistant focal epilepsy is often challenging, with many patients experiencing lifelong seizure difficulties that are unresponsive to traditional drug therapies. Joel Becker, the CEO of NeuroPace, emphasized the urgency to address this unmet need, stating, “We are dedicated to supporting individuals affected by drug-resistant focal epilepsy and are eager to present data that can potentially transform their lives at the AAN 2025.”

Inside the RNS System

The RNS System by NeuroPace stands out as the first and only brain-responsive platform that provides real-time, personalized seizure treatment, marking a significant advancement in patient care. Attendees at the AAN Annual Meeting can witness the RNS System firsthand at booth #1642, which will provide an in-depth look at this cutting-edge technology.

Highlights of NeuroPace Presentations

NeuroPace is set to engage with the neurological community through various presentations at the AAN Annual Meeting:

  • Oral Presentation: Multicenter Post-Approval Study of the RNS System in Focal Epilepsy
    Monday, April 7, from 5:06 PM to 5:18 PM PDT in SDCC Room 29A.
    This presentation will be conducted by Dawn Eliashiv, MD, FAAN, from UCLA.
  • Presentation of the PAS Study at the Exhibitor Hall Stage
    Tuesday, April 8, from 12:00 PM to 12:20 PM PDT at the Exhibitor Presentation Stage Aisle 2100.
    Martha Morrell, MD, Chief Medical Officer, and Barbara Jobst, MD from Dartmouth will lead this session.
  • Encore Presentations: Multicenter Post-Approval Study of the RNS System in Focal Epilepsy
    Clinicians unable to attend can participate through an encore webinar on Tuesday, April 8, at 8:00 AM PDT and Friday, April 11, at 12:00 PM PDT, with presentations from Martha Morrell, MD and Dawn Eliashiv, MD.

Looking to the Future: NeuroPace's Vision

NeuroPace remains committed to advancing its RNS System as a key treatment option for drug-resistant epilepsy, emphasizing the platform's potential to improve the quality of life for countless patients. The company is poised to lead the way in establishing better care standards and personalized solutions for individuals grappling with severe brain disorders.

More Information

Attendees interested in learning more about the RNS System are invited to visit NeuroPace at booth #1642 during the AAN Annual Meeting. For those unable to attend, comprehensive information can be explored at their official website.

Frequently Asked Questions

What is NeuroPace, Inc.?

NeuroPace, Inc. is a medical device company dedicated to improving the lives of those with epilepsy through innovative technology, notably the RNS System.

What is the RNS System?

The RNS System is a unique neuromodulation platform designed to deliver personalized, real-time treatment for patients with drug-resistant focal epilepsy.

Where will NeuroPace present their study data?

NeuroPace will present its study data during the AAN 2025 Annual Meeting in San Diego, with specific sessions on April 7 and April 8.

How can I attend the encore presentations?

Clinicians can join the encore presentations that will be held online on April 8 and April 11; registration details will be available through NeuroPace.

How does the RNS System benefit patients?

The RNS System aims to provide patients with real-time treatment options, addressing seizures more effectively than traditional medications.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Taiwan TPU Alliance Set to Showcase at COMPAMED

Updated Category News Views 46

Alliance Puts Taiwan on the TPU Map Here's the scoop: Taiwan is hitting the big stage at COMPAMED 2026 with a mighty alliance led by Towards Buddha Co., Ltd. Now, this isn't some run-of-the-mill trade show appearance. It's about making waves in the medical thermoplastic polyurethane (TPU) sector. A Coalition of Industry Experts Towards Buddha has folded its sleeves and...

Continue Reading
Interfuse Unveils Niesen.com: A New Digital Hub

Updated Category News Views 13

Diving into Digital Heritage There’s something brewing in Madison, Wisconsin—a concoction of tech, history, and a dash of creative oomph. Interfuse, the tech-savvy brains behind digital platforms and publishing wonders, has rolled out Niesen.com. It’s like a virtual playground for anyone with a link to, or curiosity about, the Niesen name. But this isn’t just some...

Continue Reading
PCB Technologies Hits Record Q3 Sales: $62M in Orders

Updated Category News Views 21

PCB Technologies' Stellar Q3: More Than Just Numbers PCB Technologies isn't just riding the wave; it's practically surfing on a tsunami with its latest Q3 financial results. A mix of hard-hitting figures showcases not just growth, but a strategic leap that investors should really be paying attention to. It's about time we peel back the layers and understand what these...

Continue Reading
Villas of Distinction Shines: Bags 11th Gold Travvy

Updated Category News Views 82

Claiming Top Spot Repeatedly Another year, another accolade—Villas of Distinction has clutched its 11th Gold Travvy Award for "Best Villa Rental Company – Overall." This accolade ain't no small potatoes, as it's a testament to the company's unwavering excellence recognized by travel advisors worldwide. These folks, who have their fingers on the pulse of the industry,...

Continue Reading
Gold.com Faces Fiduciary Investigation by Levi & Korsinsky

Updated Category News Views 42

Gold.com in Hot Water: What Shareholders Need to Know You ever wonder how firms like Gold.com find themselves in sticky situations before the ink's dry on the quarterly report? Well, strap in because Levi & Korsinsky, LLP is poking around to see if some officers and directors over there have taken a stroll down Breach Avenue. And let me tell you, if you're holding onto...

Continue Reading
ChipMOS Sees 30.9% YoY Revenue Jump in October

Updated Category News Views 46

ChipMOS's Revenue Surge: More Than Numbers If there's one thing Wall Street loves, it's a good comeback story. ChipMOS Technologies Inc. (Taiwan Stock Exchange: 8150, Nasdaq: IMOS) seems to be writing its own version with a jaw-dropping 30.9% year-over-year revenue growth this October. Time to perk those ears up because this isn't just about numbers; it's about a...

Continue Reading
State Grid's Green Leap at COP31: Stepping into Action

Updated Category News Views 142

Electrification Takes Center Stage at COP31 Well, the folks over in Antalya are buzzing, and not just about their baklava. At COP31, the conversation's a whirlwind of electrification and industrial parks, and right in the thick of it is State Grid. They're not just pumping out kilowatts anymore; they're turning entire parks into green machines. This ain't just corporate...

Continue Reading
From Battlefield to Kitchen: Veterans Bolster Dining

Updated Category News Views 51

Honoring Military Culinarians: Unsung Heroes Some might overlook the connection between military service and the culinary world, but let me tell you, it's a tight bond. These service members turn their battlefield grit into culinary gold, managing to keep the wheels turning in our beloved food industry. Every Veterans Day, it's the perfect time to shine a light on their...

Continue Reading
Lundbeck Boosts 2026 Guidance with Strong U.S. Sales

Updated Category News Views 32

Quick Shift in Financial Outlook When a company like Lundbeck tweaks its financial projections upward, it kicks up some dust. The folks over in Denmark have decided to up their game in terms of revenue and EBITDA expectations for 2026. Yeah, you heard that right. All those numbers are getting a makeover because Vyepti® is doing better than a lot of folks anticipated,...

Continue Reading
Gildan Faces Class Action Over Alleged Market Missteps

Updated Category News Views 82

Legal Storm Brews Over Gildan's Securities Conduct Listen, investors are no strangers to turbulence. But when a company's integrity takes a nosedive, that's when things get precarious fast. Gildan Activewear Inc. (NYSE: GIL) finds itself neck-deep in legal trouble, thanks to alleged securities law violations. On November 9, 2026, DJS Law Group got the ball rolling on a...

Continue Reading